Olaregen is working closely with Joe Moscato and his team to develop an agreement with China. Olaregen is providing an exclusive sublicense to the licensee to make, use and sell products utilizing a proprietary Excellagen and related technologies for the treatment of 17 types of wounds including non-healing wounds. This agreement will be with BEIJING YOUFENG BIOLOGICAL TECHNOLOGY COMPANY, LTD.
(3)
(0)
Generex Biotechnology Corp. (GNBTQ) Stock Research Links